TrialsgrambetaRCTs are beautiful

PEPTIC

2020

Proton Pump Inhibitor versus Histamine-2 Receptor Blocker for Ulcer Prophylaxis

In 26,982 ventilated ICU patients, PPI prophylaxis did not change 90-day in-hospital mortality versus H₂-receptor antagonists.

Result

Efficacy: 90-day in-hospital mortalityRR 1.05

Below 1 favours PPI prophylaxis, above 1 favours H₂-receptor antagonists.

Event rates
Absolute difference
0.8 points

The absolute difference is derived from the event rates.

Also reported: No difference in infectious complications.

Original publication
Subtopic
Stress-ulcer prophylaxis
Design
Cluster-randomised crossover trial, 50 ICUs across Australia, New Zealand, Canada, England, Ireland
Relevance
Supporting: context rather than must-know.
Source
PEPTIC Investigators. JAMA. 2020;323(7):616-626.doi 10.1001/jama.2019.22190

Discussion & critique

Either agent acceptable; modern preference is PPI based on REVISE.

Discussed in podcasts